Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02511444 · ClinicalTrials.gov registry record · NA

Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor

A NA study, sponsored by MemorialCare Health System.

Completed
Registry status
NA
Development phase
342
Enrollment target

NCT02511444: Completed NA study, sponsored by MemorialCare Health System.

NCT02511444 is a NA study that has completed, run by MemorialCare Health System. The registered enrollment target is 342 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02511444, a NA study, has completed, sponsored by MemorialCare Health System.

COMPLETED
Registry status
NA
Development phase
342 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the test characteristics of a rapid intrapartum real- time polymerase chain reaction (RT-PCR) compared to the intrapartum GBS culture as the standard in preterm patients presenting with threatened preterm labor or with obstetric indications for preterm delivery.

Interventions

  • OTHER GBS culture and real time PCR

Trial Details

FieldValue
Enrollment Target 342 participants
Start Date 2015-07
Est. Completion 2019-12
Phase NA
MemorialCare Health System

21 total trials

What the finished NCT02511444 record still lists

NCT02511444 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).

The record links to 0 conditions, and to 1 intervention - of which GBS culture and real time PCR is the first listed.

NCT02511444 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02511444 about?

NCT02511444 is a clinical study titled "Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor". The purpose of this study is to evaluate the test characteristics of a rapid intrapartum real- time polymerase chain reaction (RT-PCR) compared to the intrapartum GBS culture as the standard in preterm patients presenting with threatened preterm labor or with obstetric indications for preterm delive...

What is the current status of trial NCT02511444?

This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2015-07. Estimated completion is 2019-12.

What interventions are being tested in trial NCT02511444?

The interventions under investigation include: GBS culture and real time PCR (OTHER).

Who is sponsoring clinical trial NCT02511444?

This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02511444's enrollment target sits among peer trials

342 302nd of 2000 higher than 1,699 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283850 · 342 participants · Phase 2

    Surviving PEA in Roanoke (SPEAR) Study

  • NCT05714085 · 342 participants · Phase 2

    Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • NCT06188702 · 342 participants · Phase 1

    S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

  • NCT06544941 · 342 participants · NA

    Improving Maternal Sleep and Mental Health

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02511444, the US trial registry maintained by the National Library of Medicine. NCT02511444 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.